Compare Applovin Corporation (APP) vs 22nd Century Group Inc (XXII) Price & Performance

AppLovin (APP) trades at $310.95, down 8.27% over 24 hours, reflecting recent bearish momentum after a Q2 2026 earnings miss. The stock shows strong profitability with a 64.58% net income margin and robust revenue growth of 53% YoY in Q2, but faces technical pressure with a bearish signal from moving averages. Recent news highlights a Bank of America downgrade to Neutral on August 11, 2026, citing uncertainty around sustaining 30% revenue growth, contributing to the stock's decline.

The outlook is mixed: strong fundamentals and an 80.77% analyst buy rating with a $556.53 consensus price target suggest upside, but execution risks and technical weakness pose near-term challenges. Investors should weigh high valuation multiples against growth sustainability concerns.

XXII trades at $4.38, up 0.69% with neutral technical signals. The company shows concerning fundamentals with negative profit margins (-65.76% net income margin) and ROE of -130.19%, though valuation ratios appear low (P/S 0.03, P/B 0.07). Recent corporate actions include a 20:1 reverse stock split in June 2026. Analyst sentiment remains positive with 75% buy ratings, while the company expands VLN® product distribution in key markets like California and New York.

The outlook remains speculative given persistent losses despite revenue generation. Investment opportunity lies in successful execution of reduced-nicotine cigarette expansion and FDA regulatory progress. Key risks include continued cash burn, competitive pressures, and dependency on regulatory approvals for growth catalysts.